Bone mineralization pathway

The bone mineralization pathway describes the orchestrated physiological processes, cellular machinery, and enzymatic activities regulating the deposition of minerals (mainly calcium and phosphate as hydroxyapatite) into the bone extracellular matrix. Key steps include matrix vesicle secretion by osteoblasts and chondrocytes, the enzymatic generation of inorganic phosphate by alkaline phosphatase (ALPL/TNSALP), and the nucleation and growth of hydroxyapatite crystals within collagen fibrils. Numerous signaling pathways—such as those mediated by parathyroid hormone (via PTH1R), Wnt/β-catenin, and BMP—modulate the activity of osteoblasts, osteoclasts, and osteocytes, ensuring the balance between bone formation and bone resorption. Disruptions to this pathway lead to diseases of bone fragility or abnormal mineralization, which are treatable by drugs that target different components of this multifactorial system.

Other names

Mineralization pathwayskeletal mineralizationbone biomineralizationossification pathway

Inhibition of bone resorption (e.g., bisphosphonates, denosumab); Promotion of bone formation (e.g., teriparatide, abaloparatide, romosozumab); Modulation of parathyroid hormone receptor signaling; Alteration of osteoblast/osteoclast activity